This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: The First Affiliated Hospital, Third Military University, Pla, Tianjin Chase Sun Pharmaceutical Co., Ltd. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Jingcheng Yang in Sepsis Treatment
Introduction
Jingcheng Yang is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for sepsis. His innovative work has the potential to impact clinical practices significantly.
Latest Patents
Jingcheng Yang holds 1 patent for his invention titled "Salts of kukoamine B, preparation method and use thereof." This patent details the preparation method and pharmaceutical applications of salts of kukoamine B in the prevention and treatment of sepsis. Experimental results indicate that these salts effectively antagonize key factors that induce sepsis, offering a promising new approach in a field where effective treatments are currently lacking.
Career Highlights
Throughout his career, Jingcheng Yang has worked with reputable organizations, including Tianjin Chase Sun Pharmaceutical Co., Ltd and The First Affiliated Hospital, Third Military University, PLA. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Jingcheng Yang has collaborated with notable colleagues such as Yan Li and Yongling Lu. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Jingcheng Yang's contributions to the field of sepsis treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only addresses a critical need in healthcare but also showcases the importance of innovation in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile